Certified by Founder Lodge
Versant Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $142,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology c
Company | Date | Round | Raised |
---|---|---|---|
Abdera Therapeutics | April, 24 ,2023 | Series B | $142,000,000 |
Kate Therapeutics | June, 08 ,2023 | Series A | $51,000,000 |
Gate Bioscience | November, 02 ,2023 | Series A | $60,000,000 |
Santa Ana Bio, Inc. | June, 14 ,2024 | Series A | $168,000,000 |
858 Therapeutics | September, 27 ,2024 | Series B | $50,000,000 |